What’s the best injection for weight loss?

What’s the best injection for weight loss?

WEIGHT LOSS · 18 MIN READ
Written by Cured Pharmacy
Published on 17 April 2026

If you have been struggling with your weight and wondering whether prescription injections might finally offer the breakthrough you need, you are certainly not alone. Millions of people across the UK are now exploring weight loss injections as a clinically proven solution to achieve meaningful, sustainable results. These medications, known as GLP-1 receptor agonists, have transformed how healthcare professionals approach obesity treatment, offering hope to those who have tried countless diets and exercise programmes without lasting success. Understanding which injection might work best for your individual circumstances can feel overwhelming given the options now available, but this comprehensive guide will walk you through everything you need to know about Wegovy, Mounjaro, Saxenda and other treatments to help you make an informed decision about your weight loss journey.

Create your free account to access clinician-led weight loss consultations and personalised treatment plans.

Sign Up

Quick Summary

Weight loss injections have revolutionised obesity treatment in the UK, with several options now available that can help you lose significantly more weight than diet and exercise alone. Here is what you need to know at a glance about finding the best injection for your needs.

  • Mounjaro (tirzepatide) currently shows the highest average weight loss at approximately 20-26% of body weight in clinical trials
  • Wegovy (semaglutide) remains highly effective with around 15-17% average weight loss and extensive safety data
  • Saxenda (liraglutide) offers a good starting point with approximately 8-10% weight loss and well-established tolerability
  • All three medications require weekly or daily injections and work best alongside lifestyle modifications
  • The best injection for you depends on your health profile, weight loss goals, budget and how your body responds to treatment

Weight Loss Injection Timeline Estimator

Enter your details to see estimated weight loss projections with different injections

Table of Contents

How Weight Loss Injections Work in Your Body

Understanding the science behind weight loss injections can help you appreciate why they have become such powerful tools in the fight against obesity. These medications belong to a class called GLP-1 receptor agonists, which mimic a natural hormone your body produces called glucagon-like peptide-1. When you eat, your gut releases GLP-1 to signal fullness to your brain and regulate blood sugar levels. The injectable versions of this hormone work similarly but produce much stronger and longer-lasting effects than your natural GLP-1.

The primary mechanism through which these injections help you lose weight involves appetite suppression. By activating GLP-1 receptors in the brain, particularly in the hypothalamus which controls hunger, these medications reduce your desire to eat and help you feel satisfied with smaller portions. Many patients describe feeling genuinely uninterested in food rather than fighting constant cravings, which represents a significant departure from the willpower-dependent approach of traditional dieting. This effect on appetite is why many people wonder how to manage sugar cravings on these medications.

Beyond appetite control, weight loss injections also slow gastric emptying, meaning food stays in your stomach longer. This prolonged digestion contributes to sustained feelings of fullness between meals and can help reduce the urge to snack. Additionally, these medications improve how your body handles blood sugar by stimulating insulin release when needed and suppressing glucagon, which normally raises blood sugar. This dual action makes them particularly valuable for people with type 2 diabetes or prediabetes who are also struggling with their weight.

The newest generation of weight loss injections, represented by Mounjaro, takes this mechanism further by targeting two hormone receptors instead of one. Tirzepatide, the active ingredient in Mounjaro, activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual action appears to enhance the weight loss effect significantly compared to medications targeting GLP-1 alone, which partly explains the superior results seen in clinical trials.

  • GLP-1 receptor activation reduces appetite signals in the brain
  • Slowed gastric emptying increases feelings of fullness after meals
  • Improved insulin sensitivity helps regulate blood sugar and reduce fat storage
  • Dual-receptor medications like Mounjaro provide enhanced effects through additional pathways
  • Effects are dose-dependent, which is why treatment involves gradual dose increases

Comparing Your Options: Mounjaro vs Wegovy vs Saxenda

When deciding on the best weight loss injection, understanding the distinct characteristics of each option becomes essential. Mounjaro, Wegovy and Saxenda represent the three main choices available in the UK, each with unique properties that may make one more suitable for you than another. If you are considering where to find affordable Mounjaro or comparing it against alternatives, this section will help clarify your options.

Mounjaro (tirzepatide) has emerged as the most potent weight loss injection currently available. Manufactured by Eli Lilly, it received MHRA approval for weight management in the UK in late 2023. As a dual GIP and GLP-1 receptor agonist, it offers enhanced weight loss compared to single-target medications. The injection is administered once weekly using a pre-filled pen, with doses ranging from 2.5mg to 15mg as patients progress through the titration schedule. Most people tolerate the gradual dose increases well, though some experience temporary gastrointestinal symptoms.

Wegovy (semaglutide) from Novo Nordisk was the first GLP-1 agonist specifically approved for weight management at the 2.4mg dose. It has extensive clinical trial data supporting its use and has been available longer than Mounjaro, giving healthcare providers more real-world experience with the medication. Wegovy is also injected once weekly, making it convenient for most patients. Understanding how Wegovy works can help you determine whether this medication might suit your needs.

Saxenda (liraglutide), also from Novo Nordisk, represents an earlier generation of weight loss injections. Unlike Wegovy and Mounjaro, Saxenda requires daily injections, which some patients find less convenient. However, it has been available since 2015, providing the longest safety track record of the three options. The daily dosing can actually benefit some patients who prefer more control over their medication timing or who experience side effects that might be mitigated by the shorter-acting formulation.

Feature Mounjaro (Tirzepatide) Wegovy (Semaglutide) Saxenda (Liraglutide)
Mechanism Dual GIP/GLP-1 agonist GLP-1 agonist GLP-1 agonist
Injection Frequency Once weekly Once weekly Once daily
Maximum Dose 15mg 2.4mg 3mg
Average Weight Loss 20-26% 15-17% 8-10%
Time to Full Dose 20 weeks 16-20 weeks 5 weeks
UK Approval Date 2023 2022 2015
Private Cost (monthly) £150-250 £170-280 £150-200

Effectiveness and Expected Results

The effectiveness of weight loss injections has been demonstrated in multiple large-scale clinical trials, providing robust evidence for what patients can realistically expect. Understanding these results helps set appropriate expectations and allows you to measure your own progress against established benchmarks. It is worth noting that individual responses vary considerably, and factors such as adherence to lifestyle changes significantly influence outcomes.

Mounjaro has produced the most impressive results in clinical trials. The SURMOUNT-1 study, which involved over 2,500 participants without diabetes, showed that those receiving the highest dose (15mg) lost an average of 22.5% of their body weight over 72 weeks. Even at the lower 5mg maintenance dose, participants achieved approximately 15% weight loss. These results have positioned Mounjaro as the most effective weight loss medication currently available, though it requires commitment to the full treatment duration to achieve maximum benefits.

Wegovy demonstrated substantial effectiveness in the STEP clinical trial programme. Participants in STEP 1 lost an average of 14.9% of their body weight over 68 weeks compared to 2.4% in the placebo group. Importantly, around one-third of participants achieved weight loss of 20% or more, showing that while averages are helpful, individual responses can exceed expectations. For those wondering why Wegovy might not be working as expected, various factors including dose timing and lifestyle habits often explain suboptimal responses.

Saxenda typically produces more modest but still clinically meaningful weight loss. Studies show average weight reductions of 8-10% over one year, with approximately half of patients achieving 5% weight loss and around a quarter reaching 10% or more. While these figures are lower than Wegovy and Mounjaro, Saxenda remains an effective option, particularly for patients who may not tolerate the newer medications or who prefer daily dosing.

The timeline for seeing results also varies between medications. Most patients notice reduced appetite within the first few weeks of treatment, but significant weight loss typically becomes apparent after 2-3 months. Maximum weight loss usually occurs around 12-18 months for Wegovy and Mounjaro, though some patients continue losing weight beyond this point. You can learn more about how long Mounjaro takes to work for a detailed timeline.

  • Mounjaro achieves approximately 20-26% average weight loss at maximum doses
  • Wegovy produces around 15-17% average weight loss with significant individual variation
  • Saxenda offers 8-10% average weight loss with the longest safety record
  • Noticeable appetite changes typically occur within the first 2-4 weeks
  • Maximum weight loss usually occurs between 12-18 months of treatment

Side Effects and Safety Considerations

All weight loss injections carry potential side effects that you should understand before starting treatment. The good news is that most side effects are mild to moderate in severity, temporary in nature, and manageable with appropriate strategies. Understanding what to expect helps you prepare and reduces anxiety about starting treatment. For comprehensive guidance on managing initial symptoms, consider reading about understanding side effects when starting GLP-1 treatment.

Gastrointestinal side effects represent the most common complaints across all three medications. Nausea affects the majority of patients at some point during treatment, particularly during dose escalation phases. This typically improves as your body adjusts to each new dose level. Constipation, diarrhoea, bloating and indigestion also occur frequently. These symptoms can often be minimised by eating smaller meals, avoiding fatty or greasy foods, staying well hydrated and taking your injection at a consistent time each week.

More serious side effects, while rare, require awareness and monitoring. Pancreatitis has been reported with all GLP-1 medications, though the absolute risk remains low. Symptoms include severe abdominal pain that may radiate to the back, often accompanied by nausea and vomiting. Gallbladder problems, including gallstones, occur more frequently in people losing weight rapidly, regardless of the method used. The medications also carry theoretical concerns about thyroid C-cell tumours based on animal studies, though this has not been definitively linked to human use.

Injection site reactions are generally mild and include redness, itching or minor swelling where the injection was administered. Rotating injection sites between the abdomen, thigh and upper arm helps minimise these reactions. Some patients report fatigue or headaches, particularly in the early weeks of treatment. Learning about proper injection sites and rotation techniques can help reduce local reactions.

  • Nausea is the most common side effect, affecting 40-60% of patients initially
  • Gastrointestinal symptoms typically improve within 4-8 weeks of dose stabilisation
  • Eating smaller, frequent meals helps manage digestive discomfort
  • Serious side effects like pancreatitis are rare but require immediate medical attention
  • Injection site rotation minimises local skin reactions

Choosing the Right Injection for Your Situation

Selecting the best weight loss injection involves considering multiple factors unique to your circumstances. There is no universally correct answer because the optimal choice depends on your health history, weight loss goals, budget, lifestyle and personal preferences. A thorough assessment with a healthcare professional will help identify which medication offers the best balance of benefits and risks for you.

If maximum weight loss is your primary goal and you can tolerate the medication, Mounjaro currently offers the most significant results. Its dual-action mechanism provides enhanced effectiveness that may be particularly valuable for patients with substantial weight to lose or those who have not responded adequately to other treatments. However, it is newer to the market, meaning long-term safety data is less extensive than for the other options.

Wegovy represents an excellent middle-ground option with strong effectiveness data and a well-established safety profile. If you have cardiovascular risk factors, the extensive STEP-HFpEF trial data showing heart failure benefits may make Wegovy particularly appealing. It also benefits from years of clinical experience with semaglutide in its diabetes formulation (Ozempic), providing reassurance about its long-term use.

Saxenda might be preferred if you are cautious about newer medications or have experienced poor tolerance with weekly injections in the past. The daily dosing allows more flexibility in managing side effects, as you can temporarily reduce doses more precisely. It also remains the most affordable option for many patients, which can be significant given the long-term nature of treatment.

Your existing health conditions significantly influence the choice. Patients with type 2 diabetes might benefit from the glucose-lowering effects of any of these medications, but Mounjaro has shown particularly strong results for blood sugar control. Those with a history of pancreatitis or gallbladder disease may need more careful consideration and monitoring. Mental health conditions, eating disorders or a history of significant gastrointestinal problems should all be discussed with your prescriber.

  • Mounjaro offers maximum weight loss potential with dual-receptor action
  • Wegovy provides strong effectiveness with extensive cardiovascular safety data
  • Saxenda suits those preferring daily dosing or with tighter budgets
  • Existing health conditions significantly influence the optimal choice
  • Personal factors like needle tolerance and lifestyle also matter

Cost and Access in the UK

Understanding the cost implications and access routes for weight loss injections helps you plan realistically for treatment. In the UK, these medications can be obtained through the NHS for eligible patients, purchased privately through online pharmacies or clinics, or accessed through employer-sponsored health programmes. Each route has different requirements, costs and waiting times that you should consider.

NHS access to weight loss injections is limited by strict eligibility criteria and local commissioning decisions. Generally, you may qualify if you have a BMI of 35 or higher (or 32.5 for certain ethnic groups) with at least one weight-related health condition, or a BMI of 40 or higher regardless of other conditions. Even if eligible, waiting lists can be substantial, and not all areas have established prescribing pathways. The recent NICE guidance for Wegovy and Mounjaro should improve access over time, but implementation varies across different NHS trusts.

Private access offers a faster route to treatment for those who can afford it. Monthly costs typically range from £150-280 depending on the medication and dose, plus any consultation fees charged by the prescribing service. Some online pharmacies offer competitive pricing, making treatment more accessible than through traditional private clinics. When choosing a private provider, ensure they are registered with the General Pharmaceutical Council and require appropriate clinical assessments before prescribing.

Long-term cost considerations matter because weight loss injections are typically intended as ongoing treatment. Stopping medication often leads to weight regain, so budgeting for continued use is important. Some patients find they can reduce doses once their weight stabilises, potentially lowering costs. Others may transition to newer or different medications as their circumstances change. Discussing the financial commitment openly with your healthcare provider helps establish realistic expectations.

  • NHS access requires meeting specific BMI and health condition criteria
  • Private treatment typically costs £150-280 monthly depending on medication
  • Online pharmacies often offer more competitive pricing than traditional clinics
  • Long-term budgeting is essential as treatment is typically ongoing
  • Insurance coverage and employer health schemes may offset some costs

Key Takeaways

  • Mounjaro (tirzepatide) currently produces the highest average weight loss at 20-26%, making it the most effective option for maximum results
  • Wegovy (semaglutide) offers 15-17% weight loss with extensive safety data and cardiovascular benefits, representing an excellent balance of effectiveness and evidence
  • Saxenda (liraglutide) provides 8-10% weight loss with the longest track record and may suit those preferring daily dosing or more affordable options
  • All weight loss injections work best when combined with reduced-calorie diets and increased physical activity, not as standalone treatments
  • The best injection for you depends on your individual health profile, weight loss goals, budget constraints and personal preferences regarding dosing frequency

When to Seek Professional Advice

Starting weight loss injections is a significant medical decision that should always involve consultation with a qualified healthcare professional. Before beginning any of these medications, you need a comprehensive assessment of your health history, current medications, blood tests and physical examination. This ensures the chosen treatment is safe and appropriate for your specific situation.

Seek immediate medical attention if you experience severe abdominal pain, persistent vomiting, signs of allergic reaction such as facial swelling or difficulty breathing, or symptoms of low blood sugar if you are diabetic. While serious side effects are uncommon, recognising warning signs ensures prompt treatment if they occur.

During treatment, maintain regular follow-up appointments to monitor your progress, manage side effects and adjust doses as needed. Your healthcare provider can help troubleshoot plateau phases, switch medications if one is not working, and ensure the treatment remains safe over time. Do not hesitate to contact your prescriber if you have concerns between scheduled appointments.

Consider seeking professional advice if you are experiencing unexpected symptoms, significant mood changes, or if you feel the medication is not working despite following guidance. Healthcare professionals can distinguish between normal treatment responses and situations requiring intervention, providing peace of mind and optimising your outcomes.

Ready to Start Your Weight Loss Journey?

Browse our clinician-approved weight loss treatments including Mounjaro, Wegovy and Saxenda with free UK delivery.

Buy Now

Frequently Asked Questions

Which weight loss injection gives the fastest results?
Mounjaro typically produces the fastest initial results due to its dual-action mechanism, with many patients reporting noticeable weight loss within the first 4-6 weeks of treatment.

Can I get weight loss injections on the NHS?
Yes, Wegovy and Mounjaro are available on the NHS for eligible patients, though strict criteria apply including BMI thresholds and weight-related health conditions.

How long do I need to take weight loss injections?
Weight loss injections are typically prescribed for ongoing use as long-term treatment, as stopping often leads to weight regain within 12 months.

Are weight loss injections safe for long-term use?
Clinical trials lasting up to 4 years show acceptable safety profiles for GLP-1 medications, though ongoing monitoring and regular check-ups remain important.

Scientific References

  1. National Institute for Health and Care Excellence. Tirzepatide for managing overweight and obesity. Technology appraisal guidance [TA1026]. Available at: https://www.nice.org.uk/guidance/ta1026
  2. Medicines and Healthcare products Regulatory Agency. Semaglutide (Wegovy) 2.4 mg: summary of product characteristics. Available at: https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
  3. NHS England. Specialist Weight Management Services. Available at: https://www.england.nhs.uk/ourwork/clinical-policy/obesity/
Back to blog